Novavax Reverses Winning Spree On Yet Another Delay For Its Covid Vaccine
Novavax (NVAX) said it won’t ask the Food and Drug Administration to authorize its Covid vaccine until late this year, and NVAX stock tanked Friday.
XThis is the third timeline delay for the Novavax vaccine. Previously, the biotech company said it would…
